What is it about?

Complements related disease

Featured Image

Why is it important?

High prevalence of mutation associated atypical HUS

Perspectives

First published cohort in the middle east about children with atypical HUS

Abdulaziz Bamhraz
McMaster University

Read the Original

This page is a summary of: Improved Renal Recovery with Eculizumab Therapy among Children with High Prevalence of Mutation-Associated Atypical Hemolytic Uremic Syndrome: A Retrospective Cohort Study, Kidney and Blood Pressure Research, November 2020, Karger Publishers, DOI: 10.1159/000510612.
You can read the full text:

Read

Contributors

The following have contributed to this page